Global Orthostatic Hypotension Drugs Market 2024-2028

Orthostatic Hypotension Drugs Market 2024-2028


The orthostatic hypotension drugs market is forecasted to grow by USD 537.4 mn during 2023-2028, accelerating at a CAGR of 7.7% during the forecast period. The report on the orthostatic hypotension drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of oh in geriatric population, increasing prevalence of chronic diseases associated with high risk of oh, and high market growth opportunities for oh drugs in emerging countries.

Technavio's orthostatic hypotension drugs market is segmented as below:

By Product
  • Midodrine
  • Northera (droxidopa)
  • Fludrocortisone
  • Others
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the research and development of new drugs for oh treatment as one of the prime reasons driving the orthostatic hypotension drugs market growth during the next few years. Also, use of combination therapy in oh treatment and adoption of fludrocortisone as off-label first-line pharmacotherapy will lead to sizable demand in the market.

The report on the orthostatic hypotension drugs market covers the following areas:
  • Orthostatic Hypotension Drugs Market sizing
  • Orthostatic Hypotension Drugs Market forecast
  • Orthostatic Hypotension Drugs Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading orthostatic hypotension drugs market vendors that include Alchemy Laboratories Pvt Ltd., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Apotex Inc., Avadel Pharmaceuticals plc, Baxter International Inc., Brancaster Pharma Ltd., Enaltec Labs Pvt. Ltd., Endo International Plc, H Lundbeck AS, Hikma Pharmaceuticals Plc, Manus Aktteva Biopharma LLP, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Theravance Biopharma Inc., and Viatris Inc.. Also, the orthostatic hypotension drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
5.1 Global Orthostatic Hypotension Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Orthostatic Hypotension Drugs Market 2018 - 2022 ($ million)
5.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
5.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
6.1 AI Impact on Orthostatic Hypotension Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Product
8.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 Midodrine - Market size and forecast 2023-2028
Chart on Midodrine - Market size and forecast 2023-2028 ($ million)
Data Table on Midodrine - Market size and forecast 2023-2028 ($ million)
Chart on Midodrine - Year-over-year growth 2023-2028 (%)
Data Table on Midodrine - Year-over-year growth 2023-2028 (%)
8.4 Northera (droxidopa) - Market size and forecast 2023-2028
Chart on Northera (droxidopa) - Market size and forecast 2023-2028 ($ million)
Data Table on Northera (droxidopa) - Market size and forecast 2023-2028 ($ million)
Chart on Northera (droxidopa) - Year-over-year growth 2023-2028 (%)
Data Table on Northera (droxidopa) - Year-over-year growth 2023-2028 (%)
8.5 Fludrocortisone - Market size and forecast 2023-2028
Chart on Fludrocortisone - Market size and forecast 2023-2028 ($ million)
Data Table on Fludrocortisone - Market size and forecast 2023-2028 ($ million)
Chart on Fludrocortisone - Year-over-year growth 2023-2028 (%)
Data Table on Fludrocortisone - Year-over-year growth 2023-2028 (%)
8.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
8.7 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
9 Customer Landscape
9.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Geographic Landscape
10.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
10.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
10.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
10.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
10.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
10.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
10.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
10.8 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
10.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
10.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
10.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
10.12 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ million)
Data Table on India - Market size and forecast 2023-2028 ($ million)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
10.13 Mexico - Market size and forecast 2023-2028
Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Chart on Mexico - Year-over-year growth 2023-2028 (%)
Data Table on Mexico - Year-over-year growth 2023-2028 (%)
10.14 Brazil - Market size and forecast 2023-2028
Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Chart on Brazil - Year-over-year growth 2023-2028 (%)
Data Table on Brazil - Year-over-year growth 2023-2028 (%)
10.15 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
10.16 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
10.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
11 Drivers, Challenges, and Opportunity/Restraints
11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
11.4 Market opportunities/restraints
12 Competitive Landscape
12.1 Overview
12.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
12.3 Landscape disruption
Overview on factors of disruption
12.4 Industry risks
Impact of key risks on business
13 Competitive Analysis
13.1 Companies profiled
Companies covered
13.2 Company ranking index
Company ranking index
13.3 Market positioning of companies
Matrix on companies position and classification
13.4 Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc. - Overview
Amneal Pharmaceuticals Inc. - Business segments
Amneal Pharmaceuticals Inc. - Key news
Amneal Pharmaceuticals Inc. - Key offerings
Amneal Pharmaceuticals Inc. - Segment focus
SWOT
13.5 Apotex Inc.
Apotex Inc. - Overview
Apotex Inc. - Product / Service
Apotex Inc. - Key news
Apotex Inc. - Key offerings
SWOT
13.6 Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc - Overview
Avadel Pharmaceuticals plc - Product / Service
Avadel Pharmaceuticals plc - Key offerings
SWOT
13.7 Baxter International Inc.
Baxter International Inc. - Overview
Baxter International Inc. - Business segments
Baxter International Inc. - Key news
Baxter International Inc. - Key offerings
Baxter International Inc. - Segment focus
SWOT
13.8 Endo International Plc
Endo International Plc - Overview
Endo International Plc - Business segments
Endo International Plc - Key news
Endo International Plc - Key offerings
Endo International Plc - Segment focus
SWOT
13.9 H Lundbeck AS
H Lundbeck AS - Overview
H Lundbeck AS - Product / Service
H Lundbeck AS - Key offerings
SWOT
13.10 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
13.11 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
13.12 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
13.13 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
14 Appendix
14.1 Scope of the report
14.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
14.3 Currency conversion rates for US$
Currency conversion rates for US$
14.4 Research methodology
Research methodology
14.5 Data procurement
Information sources
14.6 Data validation
Data validation
14.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
14.8 Data synthesis
Data synthesis
14.9 360 degree market analysis
360 degree market analysis
14.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits10: Overview on criticality of inputs and factors of differentiation
Exhibits11: Overview on factors of disruption
Exhibits12: Impact of drivers and challenges in 2023 and 2028
Exhibits13: Parent Market
Exhibits14: Data Table on - Parent Market
Exhibits15: Market characteristics analysis
Exhibits16: Value chain analysis
Exhibits17: Offerings of companies included in the market definition
Exhibits18: Market segments
Exhibits19: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits20: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits21: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits22: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits23: Historic Market Size - Data Table on Global Orthostatic Hypotension Drugs Market 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits25: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits26: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits27: Five forces analysis - Comparison between 2023 and 2028
Exhibits28: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits29: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits30: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits31: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits32: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits33: Chart on Market condition - Five forces 2023 and 2028
Exhibits34: Chart on Product - Market share 2023-2028 (%)
Exhibits35: Data Table on Product - Market share 2023-2028 (%)
Exhibits36: Chart on Comparison by Product
Exhibits37: Data Table on Comparison by Product
Exhibits38: Chart on Midodrine - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Midodrine - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Midodrine - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Midodrine - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Northera (droxidopa) - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Northera (droxidopa) - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Northera (droxidopa) - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Northera (droxidopa) - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Fludrocortisone - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Fludrocortisone - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Fludrocortisone - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Fludrocortisone - Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Product ($ million)
Exhibits55: Data Table on Market opportunity by Product ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits110: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits111: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits113: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits114: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits115: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits116: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits117: Market opportunity By Geographical Landscape ($ million)
Exhibits118: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits119: Impact of drivers and challenges in 2023 and 2028
Exhibits120: Overview on criticality of inputs and factors of differentiation
Exhibits121: Overview on factors of disruption
Exhibits122: Impact of key risks on business
Exhibits123: Companies covered
Exhibits124: Company ranking index
Exhibits125: Matrix on companies position and classification
Exhibits126: Amneal Pharmaceuticals Inc. - Overview
Exhibits127: Amneal Pharmaceuticals Inc. - Business segments
Exhibits128: Amneal Pharmaceuticals Inc. - Key news
Exhibits129: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits130: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits131: SWOT
Exhibits132: Apotex Inc. - Overview
Exhibits133: Apotex Inc. - Product / Service
Exhibits134: Apotex Inc. - Key news
Exhibits135: Apotex Inc. - Key offerings
Exhibits136: SWOT
Exhibits137: Avadel Pharmaceuticals plc - Overview
Exhibits138: Avadel Pharmaceuticals plc - Product / Service
Exhibits139: Avadel Pharmaceuticals plc - Key offerings
Exhibits140: SWOT
Exhibits141: Baxter International Inc. - Overview
Exhibits142: Baxter International Inc. - Business segments
Exhibits143: Baxter International Inc. - Key news
Exhibits144: Baxter International Inc. - Key offerings
Exhibits145: Baxter International Inc. - Segment focus
Exhibits146: SWOT
Exhibits147: Endo International Plc - Overview
Exhibits148: Endo International Plc - Business segments
Exhibits149: Endo International Plc - Key news
Exhibits150: Endo International Plc - Key offerings
Exhibits151: Endo International Plc - Segment focus
Exhibits152: SWOT
Exhibits153: H Lundbeck AS - Overview
Exhibits154: H Lundbeck AS - Product / Service
Exhibits155: H Lundbeck AS - Key offerings
Exhibits156: SWOT
Exhibits157: Novartis AG - Overview
Exhibits158: Novartis AG - Business segments
Exhibits159: Novartis AG - Key news
Exhibits160: Novartis AG - Key offerings
Exhibits161: Novartis AG - Segment focus
Exhibits162: SWOT
Exhibits163: Pfizer Inc. - Overview
Exhibits164: Pfizer Inc. - Product / Service
Exhibits165: Pfizer Inc. - Key news
Exhibits166: Pfizer Inc. - Key offerings
Exhibits167: SWOT
Exhibits168: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits169: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits170: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits171: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits172: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits173: SWOT
Exhibits174: Viatris Inc. - Overview
Exhibits175: Viatris Inc. - Business segments
Exhibits176: Viatris Inc. - Key news
Exhibits177: Viatris Inc. - Key offerings
Exhibits178: Viatris Inc. - Segment focus
Exhibits179: SWOT
Exhibits180: Inclusions checklist
Exhibits181: Exclusions checklist
Exhibits182: Currency conversion rates for US$
Exhibits183: Research methodology
Exhibits184: Information sources
Exhibits185: Data validation
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Data synthesis
Exhibits188: 360 degree market analysis
Exhibits189: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings